F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths​

F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths​

RSS » New York Times News » NYTHealth

F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths​

November 15, 2025

14HS-FDA-DUCHENNE-vmzj-mediumSquareAt3X-B5LbbB-rss

 A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.  

Creator: The New York Times (NYTHealth)

Source URL

Related Posts

  • One Health Insights
Rethinking Cures: The Truth Behind Responsible Antibiotic Use
Responsible Antibiotic Use
  • Public Awareness and Engagement
Promoting Health: Managing Diabetes Together
Managing Diabetes Together
  • Sustainable Practices
Building Health Through Sustainable Recycling Practices
Sustainable Recycling Practices

Most Recent

  • Book and Article Reviews
One Health Book Review: A Comprehensive Analysis 
One Health Book Review
  • Careers
Value of MPH in One Health: Career Benefits and Impact
Value of MPH in One Health
  • Community Stories
Malaria Control Strategies: One Health in Action
Malaria Control Community Stories

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts